Actuate Therapeutics ACTU
NASDAQ ACTU
$0.32 +0.01 (+3.57%)
As of: Nov 10, 2026 · 1:20 PM EST

Actuate Therapeutics (ACTU) Total Liabilities (2023 - 2026)

Updated

Actuate Therapeutics (ACTU) recorded Total Liabilities of $4.21 million in Q2 2026, down 56.2% from $9.62 million a year earlier.

Analysis

Actuate Therapeutics (ACTU) Total Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Actuate Therapeutics reported Total Liabilities of $6.11 million, down 33.7% from FY2024.

  • Across earlier years, Total Liabilities came in at $9.21 million in FY2024 (-91.0%) and $102.62 million in FY2023.
  • The Q2 2026 figure is the lowest quarterly Total Liabilities in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 115.90 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 152.26 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 80.09 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 65.46 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 38.37 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 115.70 Bn
10 Actuate Therapeutics 7.56 Mn -35.08 Mn - 4.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.21 Mn
Dec 31, 2025 6.11 Mn
Sep 30, 2025 6.78 Mn
Jun 30, 2025 9.62 Mn
Mar 31, 2025 9.57 Mn
Dec 31, 2024 9.21 Mn
Sep 30, 2024 8.90 Mn
Jun 30, 2024 115.99 Mn
Dec 31, 2023 102.62 Mn
API Access

Actuate Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=ACTU&period=max&api_key=YOUR_API_KEY